Alzheimer's disease and melatonin

International Congress Series

Volumn 1252, Issue C, 2003, Pages 395-398

  Matsubara, Etsuro ^a   Shoji, Mikio ^a   Murakami, Tetsuro ^a   Kawarabayashi, Takeshi ^a   Abe, Koji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Amyloid ; Anti amyloidogenic properties of melatonin; Antioxidant properties of melatonin; Melatonin

Indexed keywords

EID: 4644249295     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(03)00019-0     Document Type: Article

References (34)

1. S. Sisodia Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing Science 248 1990 492 495
2. P. Seubert Isolation and quantification of soluble Alzheimer's β peptide from biological fluids Nature 359 1992 325 327
3. M. Shoji Production of the Alzheimer amyloid β protein by normal proteolytic processing Science 258 1992 126 129
4. C. Vigo-Pelfrey Characterization of β-amyloid peptide from human cerebrospinal fluid J. Neurochem. 61 1993 1965 1968
5. J. Ghiso Alzheimer's soluble amyloid β is a normal component of human urine FEBS Lett. 408 1997 105 108
6. J. Nästrand Relative abundance of Alzheimer Aβ amyloid peptide variants in Alzheimer disease and normal aging Proc. Natl. Acad. Sci. U. S. A. 91 1994 8378 8382
7. M. Tabaton Soluble amyloid β protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid Biochem. Biophys. Res. Commun. 200 1994 1598 1603
8. J.K. Teller Presence of soluble amyloid β peptide precedes amyloid plaque formation in Down's syndrome Nat. Med. 2 1996 93 95
9. H. Funato Quantitation of amyloid β-protein (Aβ) in the cortex during aging and in Alzheimer's disease Am. J. Pathol. 152 1998 1633 1640
10. M.A. Pappolla Dual anti-amyloidogenic and anti-oxidant properties of melatonin K. Iqbal B. Winblas H.M. Wisniewski A New Therapy for Alzheimer's Disease? 1999 Wiley New, York 661 669
11. M.A. Pappolla An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease J. Neural Transm. 107 2000 203 231
12. F. Magri Biochemical and cerebral morphometric correlates of physiological aging and senile dementia Aging (Milan) 9 1997 53 54
13. K. Mishima Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia Acta Psychiatr. Scand. 89 1994 1 7
14. R.J. Reiter The aging pineal gland and its physiological consequences BioEssays 14 1992 169 175
15. E. Souetre Abnormal melatonin response to 5-methoxypsoralen in dementia Am. J. Psychiatry 146 1989 1037 1040
16. R.Y. Liu Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease and apolipoprotein E-ε4/4 genotype J. Clin. Endocrinol. Metab. 84 1999 323 327
17. S.F. Pang Melatonin in the chicken brain: its origin, diurnal variation, and regional distribution Gen. Comp. Endocrinol. 22 1974 499 506
18. M.A. Pappolla Inhibition of Alzheimer β-fibrillogenesis by melatonin J. Biol. Chem. 273 1998 7185 7189
19. B. Poeggeler Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Aβ peptide Biochemistry 40 2001 14995 15001
20. C. Soto Fibrillogenesis of synthetic amyloid-beta peptides is dependent on their initial secondary structure Neurosci. Lett. 200 1995 105 108
21. M.R. Harrigan β Amyloid is neurotoxic in hippocampal slice culture Neurobiol. Aging 16 1995 779 789
22. L.K. Simmons Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro Mol. Pharmacol. 45 1994 373 379
23. M.A. Pappolla Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing anti-oxidant therapies in vivo Am. J. Pathol. 152 1998 871 877
24. D. Praticò Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis J. Neurosci. 21 12 2001 4183 4187
25. K. Uryu Repetitive mild brain trauma accelerates Aβ deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis J. Neurosci. 22 2 2002 446 454
26. S. Cuzzocrea Protective effect of melatonin in a non-septic shock model induced by zymosan in the rat J. Pineal Res. 25 1998 24 33
27. E. Gilad Melatonin is a scavenger of peroxynitrite Life Sci. 60 10 1997 PL169 PL174
28. C. Behl Hydrogen peroxide mediates amyloid beta protein toxicity Cell 77 6 1994 817 827
29. C.M. Cagnoli Melatonin protects neurons from singlet oxygen-induced apoptosis J. Pineal Res. 18 1995 222 226
30. M. King The excited states of melatonin Photochem. Photobiol. 65 1997 538 542
31. L.Y. Zang Scavenging of reactive oxygen species by melatonin Biochim. Biophys. Acta 1425 1998 469 477
32. P.F. Good Evidence of neuronal oxidative damage in Alzheimer's disease Am. J. Pathol. 149 1 1996 21 28
33. M.A. Smith Widespread peroxynitrite-mediated damage in Alzheimer's disease J. Neurosci. 17 1997 2653 2657
34. Y.J. Chyan Potent neuroprotective properties against the Alzheimer β-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid J. Biol. Chem. 274 34 1999 21937 21942